Your browser doesn't support javascript.
loading
Clinical characteristics and risk factors for the isolation of multi-drug-resistant Gram-negative bacteria from critically ill patients with COVID-19.
Baiou, A; Elbuzidi, A A; Bakdach, D; Zaqout, A; Alarbi, K M; Bintaher, A A; Ali, M M B; Elarabi, A M; Ali, G A M; Daghfal, J; Almaslamani, M A; Ibrahim, A S S; Alkhal, A; Omrani, A S.
Afiliação
  • Baiou A; Division of Critical Care, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Elbuzidi AA; Division of Critical Care, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Bakdach D; Division of Critical Care, Department of Pharmacy, Hamad Medical Corporation, Doha, Qatar.
  • Zaqout A; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Alarbi KM; Division of Internal Medicine, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Bintaher AA; Division of Critical Care, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Ali MMB; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Elarabi AM; Division of Pulmonary Medicine, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Ali GAM; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Daghfal J; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Almaslamani MA; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Ibrahim ASS; Division of Critical Care, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Alkhal A; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar.
  • Omrani AS; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar. Electronic address: aomrani@hamad.qa.
J Hosp Infect ; 110: 165-171, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33561503
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Bactérias Gram-Negativas / Estado Terminal / Farmacorresistência Bacteriana Múltipla / COVID-19 / Bactérias Gram-Negativas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Hosp Infect Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Qatar País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Bactérias Gram-Negativas / Estado Terminal / Farmacorresistência Bacteriana Múltipla / COVID-19 / Bactérias Gram-Negativas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Hosp Infect Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Qatar País de publicação: Reino Unido